Clinical Trials Directory

Trials / Completed

CompletedNCT03083821

A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting

A Clinical Study to Evaluate the Steady State Pharmacokinetics of Baraclude in Participants With Hepatitis B Virus Infection

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A Pharmacokinetics study of Baraclude in a real world clinical setting in Japan.

Conditions

Interventions

TypeNameDescription
DRUGBaracludeSpecified dose on specified day

Timeline

Start date
2017-05-16
Primary completion
2017-12-19
Completion
2017-12-19
First posted
2017-03-20
Last updated
2023-11-18
Results posted
2023-11-18

Locations

1 site across 1 country: Japan

Regulatory

Source: ClinicalTrials.gov record NCT03083821. Inclusion in this directory is not an endorsement.

A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting (NCT03083821) · Clinical Trials Directory